Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli, J R
Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. [electronic resource] - The Journal of urology Jul 2001 - 68-72 p. digital
Publication Type: Comparative Study; Journal Article
0022-5347
Adult
Aged
Carcinoma, Renal Cell--mortality
Combined Modality Therapy
Female
Humans
Interleukin-2--administration & dosage
Kidney Neoplasms--mortality
Lymph Nodes--pathology
Lymphatic Metastasis
Male
Middle Aged
Multivariate Analysis
Neoplasm Staging
Nephrectomy--methods
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Retroperitoneal Space
Retrospective Studies
Survival Rate
Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. [electronic resource] - The Journal of urology Jul 2001 - 68-72 p. digital
Publication Type: Comparative Study; Journal Article
0022-5347
Adult
Aged
Carcinoma, Renal Cell--mortality
Combined Modality Therapy
Female
Humans
Interleukin-2--administration & dosage
Kidney Neoplasms--mortality
Lymph Nodes--pathology
Lymphatic Metastasis
Male
Middle Aged
Multivariate Analysis
Neoplasm Staging
Nephrectomy--methods
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Retroperitoneal Space
Retrospective Studies
Survival Rate